Beacon Scientific Inc.

San Diego, CA

UEI
DP2PZHVMDKL4
CAGE
0QXF7
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Hispanic American Owned
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
6191 Cornerstone Ct E #111, San Diego, CA 92121, USA
Website
beacon-sci.com
Industry
  1. Industrials
  2. Commercial & Professional Services
  3. Professional Services
  4. Consulting
SIC code
73 Business Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $761,180

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Health and Human Services $761,180

Contract awards

Award Agency Obligated Awarded
Procurement of lateral flow cassettes for the rapid HIV nucleic acid diagnostic test-EO 14893 75D30126P21454 CDC Pittsburgh $356,500
Lateral flow assay strips - EO 14398 75D30126P21277 CDC Pittsburgh $170,680
Integrase inhibitor LAT flow devices - EO 14398 75D30126P21238 CDC Pittsburgh $234,000

Similar vendors

About the company

Beacon Scientific Inc., a Hispanic American-owned, self-certified small disadvantaged business based in San Diego, California, manufactures lateral flow diagnostic devices and assay strips for the Centers for Disease Control and Prevention as a prime contractor under full-and-open procurement (no set-asides used). The firm is a for-profit Subchapter S corporation structured as a minority-owned business.

All three of Beacon's recent federal awards—combined potential value $761 thousand—are purchase orders from CDC Pittsburgh issued between August and September 2026. The customer concentration is complete: CDC Pittsburgh accounts for 100% of both award count and potential value. The three awards span diagnostic-device manufacturing: a $356,500 purchase order for lateral flow cassettes for a rapid HIV nucleic acid diagnostic test (completion December 31, 2027); a $170,680 award for design and production of HIV nucleic acid lateral flow assay strips with 200 prototype and 4,000 final-unit deliverables (completion February 28, 2027), requiring detection via gold-conjugated antibodies and biotin-conjugated nucleic acids produced through loop-mediated isothermal amplification with specified sensitivity, specificity, and shelf-life targets; and a $234,000 purchase order for integrase inhibitor lateral flow devices (completion October 20, 2027). Performance occurs in San Diego, California, with the exception of one award performed in Atlanta, Georgia. All deliverables, files, and design histories transfer to CDC for future competitive manufacturing.

Activity is nascent—all three awards date to 2026—and all carry ultimate completion dates within the next twenty-four months, creating immediate recompete exposure across the entire portfolio. Beacon operates as a pure prime (100% of awards) with no subcontract footprint in the source data. The awards reflect capabilities in biotech research and development and in-vitro diagnostic substance manufacturing under NAICS 541714 and 325413.

Quick answers

Is Beacon Scientific Inc. registered in SAM.gov?

Yes. Beacon Scientific Inc.'s SAM.gov registration is active through December 31, 2026.

What is Beacon Scientific Inc.'s CAGE code?

Beacon Scientific Inc.'s CAGE code is 0QXF7, and its Unique Entity ID (UEI) is DP2PZHVMDKL4.

How much has Beacon Scientific Inc. received in federal contracts?

Federal contracts obligated $761,180 to Beacon Scientific Inc. in fiscal years 2023 through 2027.

What is Beacon Scientific Inc.'s most recent federal award?

Beacon Scientific Inc.'s most recent federal contract award is Procurement of lateral flow cassettes for the rapid HIV nucleic acid diagnostic test-EO 14893 (75D30126P21454), from CDC Pittsburgh, on September 2, 2026.

On GovTribe

See Beacon Scientific Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe